Linkedin

News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

Bio€quity Europe— May 12-14, 2023 – Dublin, Ireland

Excited to be a part of the Presenting Company Class
March 27, 2023
Read More

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19

ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid
March 13, 2023
Read More

ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank

xeVir Bio, a biotech company developing robust nanobody therapies for
January 9, 2023
Read More

Bio Partnering at JPM — January 9-12, 2023 – San Francisco, CA

ExeVir is a clinical-stage company developing novel antibody therapies that
January 5, 2023
Read More

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

ExeVir is pleased to announce today the appointment of Dr
October 20, 2022
Read More